Cytogens

Cytogens are a new generation of highly effective bioregulators created on the basis of synthesised peptide fractions. These preparations were developed at the Institute of Bioregulation and Gerontology and have proven themselves to be a reliable tool for the restoration, regeneration and rejuvenation of the body. Unlike traditional extracts, cytogens contain exact copies of the most active parts of peptide molecules, which ensures a faster and more targeted effect at the cellular level.

The process of creating cytogens is based on synthesis from natural amino acids, which allows for the concentrated working part of the peptide to be obtained without ballast substances. This approach enables the preparations to act rapidly, triggering the body's recovery functions at the initial stage of application. This is especially important for people who need to quickly mobilise the body's protective resources or recover from illness or surgery.

Physiologically active short peptides are suitable for use at any age and can be used both for the prevention of disorders in various body systems and as an adjunctive therapy for existing problems. Their versatility lies in their ability to maintain normal metabolic processes, slow down the ageing process and promote rehabilitation after injuries and surgical interventions.

It is important to understand that cytogens are the starting point in peptide therapy, laying the foundation for further recovery. As the body's condition improves, many specialists recommend switching to more powerful natural peptide complexes to consolidate the results achieved and maintain a long-term effect.